Activity Type: Knowledge-based
CE Credit: No CE is offered with this activity.
Activity Fee: Members/Non-Members - Free
Activity Date: March 22, 2022
In this activity, Drs. Gabbay and Isaacs will highlight important updates to this year’s Standards of Care in Diabetes and how those changes impact clinical care, especially as they relate to pharmaceutical care.
- Robert Gabbay, MD, PhD, Chief Scientific & Medical Officer, American Diabetes Association, Arlington, VA
- Diana Isaacs, PharmD, CDCES, BC-ADM, Endocrine Clinical Pharmacist, Cleveland Clinic, Cleveland, OH